Business Description
Amarin Corp PLC
NAICS : 325412
SIC : 2834
ISIN : US0231114044
Share Class Description:
AMRN: ADRTotal Employee Number:
80Description
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 55.12 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.22 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -1.75 | |||||
Beneish M-Score | -3.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17.6 | |||||
3-Year EBITDA Growth Rate | 31.8 | |||||
3-Year Book Growth Rate | -9.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | -12.87 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 20.03 | |||||
9-Day RSI | 34.34 | |||||
14-Day RSI | 42.08 | |||||
3-1 Month Momentum % | 1.93 | |||||
6-1 Month Momentum % | -6.7 | |||||
12-1 Month Momentum % | -14.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.48 | |||||
Quick Ratio | 2.46 | |||||
Cash Ratio | 1.71 | |||||
Days Inventory | 632.71 | |||||
Days Sales Outstanding | 198.04 | |||||
Days Payable | 155.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | 0.49 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.37 | |||||
Operating Margin % | -2.4 | |||||
Net Margin % | -15.51 | |||||
EBITDA Margin % | -11.53 | |||||
FCF Margin % | 11.8 | |||||
OCF Margin % | 11.8 | |||||
ROE % | -7.29 | |||||
ROA % | -5.09 | |||||
ROIC % | -2.77 | |||||
3-Year ROIIC % | -48.07 | |||||
ROC (Joel Greenblatt) % | -18.5 | |||||
ROCE % | -5.69 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 39.19 | |||||
PE Ratio without NRI | 21.41 | |||||
PS Ratio | 1.4 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.72 | |||||
Price-to-Free-Cash-Flow | 12.11 | |||||
Price-to-Operating-Cash-Flow | 12.11 | |||||
EV-to-EBIT | -0.36 | |||||
EV-to-EBITDA | -0.39 | |||||
EV-to-Revenue | 0.05 | |||||
EV-to-Forward-Revenue | 1.34 | |||||
EV-to-FCF | 0.38 | |||||
Price-to-GF-Value | 1.27 | |||||
Price-to-Median-PS-Value | 0.45 | |||||
Price-to-Graham-Number | 0.82 | |||||
| Price-to-Net-Current-Asset-Value | 0.73 | |||||
| Price-to-Net-Cash | 2.8 | |||||
Earnings Yield (Greenblatt) % | -277.78 | |||||
FCF Yield % | 8.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AMRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amarin Corp PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 216.762 | ||
| EPS (TTM) ($) | -1.6 | ||
| Beta | 1.0304 | ||
| 3-Year Sharpe Ratio | -0.15 | ||
| 3-Year Sortino Ratio | -0.24 | ||
| Volatility % | 26.05 | ||
| 14-Day RSI | 42.08 | ||
| 14-Day ATR ($) | 0.701576 | ||
| 20-Day SMA ($) | 15.6985 | ||
| 12-1 Month Momentum % | -14.78 | ||
| 52-Week Range ($) | 12.96 - 20.9 | ||
| Shares Outstanding (Mil) | 20.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amarin Corp PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amarin Corp PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 08:00 | In 111 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 110 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 08:00 | In 20 days | ||
| Second quarter earnings results for 2026 | 2026-07-30 | In 19 days | ||
| General meeting for 2026 | 2026-05-13 08:00 | 14.95 (-0.33%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 08:00 | 13.96 (+0.58%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 13.96 (+0.58%) | ||
| Annual report for 2025 | 2026-03-02 | 13.80 (-1.36%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-25 08:00 | 15.52 (-0.26%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-25 | 15.52 (-0.26%) |
Show
Entries
Amarin Corp PLC Frequently Asked Questions
What is Amarin Corp PLC(AMRN)'s stock price today?
The current price of AMRN is $14.88. The 52 week high of AMRN is $20.90 and 52 week low is $12.96.
When is next earnings date of Amarin Corp PLC(AMRN)?
The next earnings date of Amarin Corp PLC(AMRN) is 2026-07-30 Est..
Does Amarin Corp PLC(AMRN) pay dividends? If so, how much?
Amarin Corp PLC(AMRN) does not pay dividend.
Guru Commentaries on NAS:AMRN
No articles.
Press Release
Articles on Amarin Corp PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers